Investors Land KNSA Even Lower Than Its Secondary Stock Offering
July 23, 2020 at 13:10 PM EDT
Looking back to 2 days ago, Kiniksa Pharmaceuticals Ltd (KNSA) priced a 5,952,381 share secondary stock offering at $21.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..